Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus

Journal of Infectious Diseases

Volumn 194, Issue 3, 2006, Pages 377-384

  Kim, Sung Haro ^a,b   Bang, Ji Whan ^b   Park, Kyong Hwa ^b   Park, Wan Burn ^b   Kim, Hong Bin ^b   Kim, Nam Joong ^b   Jee, Youngmee ^a   Cho, Haewol ^a   Oh, Myoung Don ^b   Choe, Kang Won ^b  

^a Korea National Institute of Health   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LANCY VAXINA; NEUTRALIZING ANTIBODY; VACCINIA VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNITY; INFECTION SENSITIVITY; INTRACUTANEOUS TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SMALLPOX; T LYMPHOCYTE; VACCINIA VIRUS;

ADULT; FEMALE; HEAT; HUMANS; INTERFERON TYPE II; INTRADERMAL TESTS; MALE; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SMALLPOX; SMALLPOX VACCINE; VACCINIA VIRUS; VIRUS INACTIVATION;

EID: 33746364846     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505505     Document Type: Article

References (28)

1. Combadiere B, Boissonnas A, Carcelain G, et al. Distinct time effects of vaccination on long-term proliferative and IFN-γ-producing T cell memory to smallpox in humans. J Exp Med 2004; 199:1585-93.
2. Grotty S, Feigner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003; 171:4969-73.
3. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003;9:1131-7.
4. Hsieh S-M, Pan S-C, Chen S-Y, Huang P-F, Chang S-C. Age distribution for T cell reactivity to vaccinia virus in a healthy population. Clin Infect Dis 2004; 38:86-9.
5. Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. J Infect Dis 2004; 190:1286-94.
6. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Developments in vaccination and control between 1900 and 1966. In: Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID, eds. Smallpox and its eradication. Geneva: World Health Organization, 1988:277-314.
7. Benenson AS. Smallpox. In: Wehrle PF, Top FH, eds. Communicable and infectious diseases. 9th ed. St. Louis: Mosby, 1981:583-4.
8. Fenner F, Wittek R, Dumbell KR. Vaccinia virus: the tool for smallpox eradication. In: Fenner F, Wittek R, Dumbell KR, eds. The orthopox-viruses. 1st ed. San Diego: Academic Press, 1998:143-70.
9. Wulff H, Chin TD, Wenner HA. Serologic responses of children after primary vaccination and revaccination against smallpox. Am J Epidemiol 1969; 90:312-8.
10. Kim S-H, Yeo S-G, Jang H-C, et al. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 2005; 192:1066-70.
11. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1-22.
12. Benenson AS. Immediate (so-called "immune") reaction to smallpox vaccination. JAMA 1950; 143:1238-40.
13. Somekh E, Smetana Z, Tanay A, Dalai I, Babai I, Mendelson E. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing. Vaccine 2004; 23:321-4.
14. Graham BS, Belshe RB, Clements ML, et al. Vaccination of vaccine-naïve adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. J Infect Dis 1992; 166:244-52.
15. Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ. Development and validation of a gamma Interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol 2001; 8:871-9.
16. Bedson HS, Duckworth MJ. Rabbit pox: an experimental study of the pathways of infection in rabbits. J Pathol Bacteriol 1963; 85:1-20.
17. Bray M, Buller M. Looking back at smallpox. Clin Infect Dis 2004; 38:882-9.
18. Saha K, Saini CL, Gupta S, Response of specific skin hypersensitivity and haemagglutination inhibiting antibody after smallpox vaccination in human newborns and adults. Scand J Immunol 1973; 2:261-72.
19. Terzin AL, Vukovic B, Mudric V, Bankovic A. Skin reactivity and antibody response following vaccination against smallpox. J Hyg (Lond) 1974; 72:173-80.
20. Freed ER, Duma RJ, Escobar MR. Vaccinia necrosum and its relationship to impaired immunologic responsiveness. Am J Med 1972; 52:411-20.
21. Kempe CH. Studies on smallpox and complications of smallpox vaccination. Pediatrics 1960; 26:176-89.
22. Henderson DA, Borio LL, Lane JM. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, eds. Vaccine. 4th ed. Philadelphia: Elsevier, 2004: 123-53.
23. Ahmed R, Lanier G, Pamer E. Immunological memory and infection. In: Kaufmann SE, Sher A, Ahmed R, eds, Immunology of infectious diseases. 1st ed. Washington, DC: ASM Press, 2002:175-89.
24. Stittelaar KJ, Neyts J, Naesens L, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006; 439:745-8.
25. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002; 346:1275-80.
26. Talbot TR, Stapleton JT, Brady RC, et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 2004; 292:1205-12.
27. Hsieh S-M, Chen S-Y, Sheu G-C, et al. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain. Vaccine 2006; 24:510-5.
28. Belshe RB, Newman FK, Frey SE, et al. Dose-dependent neutralizing- antibody responses to vaccinia. J Infect Dis 2004; 189:493-7.